Sluggish Vaccine Campaign Raises Specter of U.S. Dysfunction

The video discusses the detection of a new COVID-19 strain in the US, highlighting its spread and the lack of screening. It addresses the challenges of vaccine distribution, particularly the need for super-cold storage, and the potential of the AstraZeneca vaccine for developing countries. The video also reviews the US's slow vaccination progress, falling short of the Trump administration's year-end target, and the logistical hurdles faced.

What is a significant concern regarding the new COVID-19 strain detected in California and Colorado?

• It causes more severe symptoms.

• It has been detected in people with travel history to the UK.

• It is spreading among people without travel history.

• It is resistant to current vaccines.

Why are developing countries betting heavily on the AstraZeneca vaccine?

• It only requires normal refrigeration.

• It is cheaper than other vaccines.

• It requires deep freezing for storage.

• It is more effective than Moderna and Pfizer.

What is a major challenge in distributing the Moderna and Pfizer vaccines?

• They are not effective.

• They have not been approved.

• They require deep freezing.

• They are too expensive.

What was the Trump administration's vaccination goal by the end of the year?

• 25 million people

• 20 million people

• 15 million people

• 10 million people

How many people had been vaccinated in the US by the end of the year?

• 1 million

• 2.7 million

• 5 million

• 10 million